SLI
1.965,96
PKT
-9,76
PKT
-0,49
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.08.15 | Holcim Neutral | UBS AG | |
07.08.15 | Roche buy | Jefferies & Company Inc. | |
06.08.15 | Zurich Insurance Sell | S&P Capital IQ | |
06.08.15 | Holcim overweight | JP Morgan Chase & Co. | |
05.08.15 | Swiss Re buy | Goldman Sachs Group Inc. | |
05.08.15 | UBS buy | Citigroup Corp. | |
04.08.15 | Swiss Re Underperform | BNP PARIBAS | |
04.08.15 | Holcim Neutral | Goldman Sachs Group Inc. | |
03.08.15 | Holcim Neutral | BNP PARIBAS | |
03.08.15 | Holcim buy | Kepler Cheuvreux | |
31.07.15 | Holcim Neutral | BNP PARIBAS | |
31.07.15 | Swiss Re neutral | Barclays Capital | |
30.07.15 | Swiss Re buy | S&P Capital IQ | |
30.07.15 | Holcim buy | Deutsche Bank AG | |
29.07.15 | Holcim kaufen | S&P Capital IQ | |
29.07.15 | UBS Underperform | BNP PARIBAS | |
29.07.15 | Zurich Insurance Neutral | UBS AG | |
29.07.15 | Roche buy | UBS AG | |
29.07.15 | Roche overweight | JP Morgan Chase & Co. | |
28.07.15 | Holcim Reduce | HSBC | |
28.07.15 | UBS overweight | JP Morgan Chase & Co. | |
28.07.15 | Holcim Neutral | UBS AG | |
28.07.15 | Roche overweight | Barclays Capital | |
27.07.15 | UBS Strong Buy | S&P Capital IQ | |
27.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
27.07.15 | ABB (Asea Brown Boveri) Neutral | Nomura | |
27.07.15 | UBS kaufen | Independent Research GmbH | |
27.07.15 | Novartis buy | UBS AG | |
27.07.15 | UBS Sell | Société Générale Group S.A. (SG) | |
24.07.15 | Roche overweight | Morgan Stanley | |
24.07.15 | UBS kaufen | Morgan Stanley | |
24.07.15 | UBS overweight | Barclays Capital | |
24.07.15 | UBS Underperform | BNP PARIBAS | |
24.07.15 | Holcim Neutral | Goldman Sachs Group Inc. | |
24.07.15 | UBS buy | Goldman Sachs Group Inc. | |
24.07.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
24.07.15 | UBS overweight | JP Morgan Chase & Co. | |
24.07.15 | UBS Neutral | UBS AG | |
24.07.15 | ABB (Asea Brown Boveri) Sell | UBS AG |